Equity research firms produce buy, sell, or hold recommendations on stocks, giving institutional investors actionable investment intelligence. They analyze company fundamentals and macroeconomic data, build financial models to project future earnings, and publish reports that move markets. From bulge-bracket investment banking desks to focused independent shops, these firms play a crucial role in increasing market efficiency.
The right research provider depends on your budget, coverage needs, and investment timeline. If you're a PE/VC associate doing pre-investment work, a corporate strategy analyst, or a founder validating a market, you need to know which firms deliver differentiated research and which ones are coasting on brand. Here's what matters.
Types of Equity Research Firms
Research providers fall into distinct categories. Each serves different clients and investment strategies, and each carries its own trade-offs around cost, objectivity, and depth.
Sell-Side Research Firms
Sell-side equity research comes from analysts at brokerage firms or investment banks like Goldman Sachs, Morgan Stanley, and JP Morgan. These teams produce street research to support trading desks and institutional client relationships. Coverage focuses on large-cap stocks with broad appeal, and reports are distributed free to institutional clients, funded through trading commissions.
Sell-side analysts cover over 700 companies across major sectors, but this model has constraints. Investment banking relationships can create subtle conflicts of interest. Regulatory requirements like the 2004 Global Research Analyst Settlement forced separation between banking and research at large U.S. firms, but the tension persists. Sell-side research roles have seen a 30% decline in headcount over ten years, meaning coverage gaps are widening, especially outside the S&P 500. See our sell-side research guide for more on how that work has changed.
Independent Research Providers
Independent research providers like Wolfe Research, Evercore ISI, and New Street Research sell research directly to buy-side clients. Their subscription-based model reduces conflicts of interest because they don't have investment banking revenue to protect.
Independent research now accounts for roughly 25-30% of U.S. equity research consumption by dollar value, up from under 5% in 2003. These firms tend to provide deeper, more specialized coverage in specific sectors. Boutiques dominate in niche areas like REITs, chemicals, and supply-chain-intensive industrials. Premium pricing reflects the quality of independent thinking and the depth of analysis you get.
Buy-Side Research Operations
Buy-side research is conducted by analysts for institutional investors. In-house teams at hedge funds, mutual funds, and asset managers focus on generating alpha through proprietary fundamental analysis and investment recommendations. This research is directly tied to portfolio construction and trading decisions, and it's not available to external clients.
Buy-side roles typically offer higher compensation potential than sell-side roles. Hedge fund analysts often have broader responsibilities, covering more ground across sectors and asset classes. The trade-off: you can't access this research externally.
Choosing the Right Research Firm
Different firms excel in different areas. Match your requirements to their strengths before signing any contract.
For Broad Market Coverage
Large financial institutions offer research coverage across all major sectors and geographies. If you need one-stop access to blue-chip analysis, macro strategy calls, and sector rotation frameworks, a bulge-bracket bank's research platform is the default choice. J.P. Morgan, BofA Securities, and Morgan Stanley topped Extel's All-America Equities Research Table in 2025.
The limitation: these firms provide limited depth on smaller companies outside the S&P 500. If you're focused on middle market or small-cap names, bank coverage won't be enough.
For Specialized Sector Expertise
Boutique firms with sector-specific focus deliver insight that generalist coverage can't match. Analysts at these shops often have operating or management experience in their covered industry, whether that's healthcare, technology, or media. They typically maintain closer relationships with company management teams and attend more specialized industry conferences.
This kind of differentiated research carries premium pricing. It's worth it when you need the depth, especially during earnings season or when evaluating a sector thesis for a private equity transaction.
For Small and Mid-Cap Coverage
Regional and independent firms like William Blair, Stifel, and Raymond James excel in growth company research. William Blair covers over 700 companies across seven sectors, and 70% of William Blair's coverage focuses on small- and mid-cap companies. The firm employs 110 analysts and research professionals. These providers are often the only institutional coverage for emerging companies, making their work indispensable for investors in the growth and middle market space.
For small-cap stocks with thin coverage, a single analyst's call can move a stock meaningfully. The quality of the lead analyst and senior analyst on a name matters more than the brand behind them.
Research Quality and Service Capabilities
Not all equity research is equal. Evaluate firms based on analytical rigor, service delivery, and how well their output integrates into your workflow.
Fundamental Analysis Depth
Equity research analysts use two core valuation frameworks: discounted cash flow (DCF) modeling and relative valuation through peer multiples like P/E and EV/EBITDA. The best research firms go further, adjusting for one-off items, accounting policy changes, debt structure, and competitive dynamics. ESG and qualitative risk factors are now standard in many reports.
Look for firms with detailed financial models, proprietary data sources, and strong industry frameworks. Track record matters — check recommendation success rates and earnings forecast accuracy. Analysts maintain relationships with company management for insights that don't show up in public filings.
Research Distribution and Access
Modern platforms provide mobile access, email alerts, and customizable research feeds. The best providers integrate with portfolio management systems and offer searchable databases of historical reports and earnings models. Direct analyst access through calls, emails, and video conferences adds significant value, particularly during timely situations like earnings surprises or M&A announcements.
How fast you get research matters. Flash notes published within hours of an event are worth more than polished reports that arrive days later.
Alternative Data and Technology
Leading research firms incorporate alternative data, including satellite imagery, social sentiment analysis, and web scraping. AI-powered screening tools and natural language processing for earnings calls are becoming table stakes. Proprietary surveys and expert network insights add qualitative texture that traditional technical analysis alone can't provide.
Platforms that embed research directly into your workflow through Excel plugins, BI dashboards, or API access are more valuable than static PDF reports.
Working with Equity Research Providers
Commission-Based Access
The traditional model embeds research costs in trading commissions. It works for active traders with significant volume but creates pressure to trade to maintain research access. This model is declining due to MiFID II in Europe, which mandates unbundling of research payments, and similar regulatory trends in the U.S. For most firms outside the large hedge fund tier, this model is increasingly impractical.
Direct Payment and Subscriptions
Transparent pricing through direct payment is the better model. Annual contracts for institutional research typically range from $50,000 to $500,000+ depending on coverage breadth, number of sectors, and analyst access. This allows for objective vendor selection based purely on research quality and lets you negotiate specific coverage needs.
In the U.S., leading independent boutiques like Evercore ISI, Wolfe Research, and Bernstein generated estimated revenues ranging from roughly $35 million to over $200 million in 2025. Analyst headcount at these firms ranges from around 20 to 100, depending on firm size and sector breadth.
15 Leading Equity Research Firms to Know
| Firm | Type | Key Strengths | Coverage Focus |
|---|---|---|---|
| JP Morgan | Sell-side | Topped Extel's 2025 All-America rankings. Massive analyst bench, strong macro resources. | Broad multi-sector, global coverage |
| Morgan Stanley | Sell-side | Widely recognized for strategy and corporate finance research. Top-three in Extel 2025 U.S. sell-side rankings. | Full-sector coverage, strong in technology and healthcare |
| Goldman Sachs | Sell-side | Award-winning analysts across sectors. Deep corporate development and risk management research. | Large-cap equities, macro strategy |
| BofA Securities | Sell-side | Ranked in the top tier of Extel's 2025 U.S. sell-side table. Strong equity markets coverage. | Broad sectors, emphasis on financials and industrials |
| Deutsche Bank | Sell-side | European strength with solid U.S. presence. Strong in credit and equity crossover research. | Global multi-sector, financials |
| Evercore ISI | Independent | Frequently ranked #1 independent. Covers 40+ sectors with experienced research analysts. | Broad independent coverage, macro and sector strategy |
| Wolfe Research | Independent | Leading independent firm. Known for independent thinking and timely calls. | TMT, industrials, consumer |
| Bernstein Research | Independent | High-quality analysts in financials and healthcare. Strong fundamental analysis tradition. | Financials, healthcare, consumer |
| William Blair | Independent | 110 analysts and research professionals. Over 70% of coverage in small- and mid-cap. Covers 700+ companies across seven sectors. | Small and mid-cap growth companies |
| Raymond James | Regional/Independent | Strong in energy, healthcare, and financials. Deep middle market relationships. | Energy, healthcare, financials, small cap |
| Oppenheimer | Regional | 37 analysts covering approximately 670 companies. 60% of S&P 500 by market cap. | Mid-cap, healthcare, technology |
| BCA Research | Independent/Macro | Global thematic research with economics and geopolitical breadth. | Macro strategy, global themes |
| Wells Fargo | Sell-side | Solid coverage in financials, real estate, and industrials. Strong middle market integration. | Financials, real estate, industrials |
| Telsey Advisory | Independent/Boutique | Focused consumer and retail sector expertise. | Consumer, retail |
| New Street Research | Independent | Differentiated research in telecom, media, technology. Subscription model with no banking conflicts. | TMT sectors |
Top firms include Evercore ISI, JP Morgan, and Goldman Sachs, but the right pick for you depends on whether you need broad coverage or focused sector depth.
For PE/VC associates, corporate strategy teams, and consultants doing primary research, these firms provide the published research layer. But published equity research is only one input. When you need primary qualitative data, expert interviews, or management-conversation-informed insights on companies that fall outside a firm's coverage universe, you need a different tool. See our hedge fund research playbook for how the buy-side uses both.
Need primary research to supplement equity coverage? FieldSignal connects you with vetted industry experts on a pay-per-use basis, with no annual retainer and no minimum commitment. See if FieldSignal fits your project.